# Merck & Co., Inc.: Form 8-K, filed Feb 3, 2026

- Company: [Merck & Co., Inc.](/companies/mrk.md) (CIK 310158)
- Form: 8-K
- Filed: 2026-02-03
- Accepted by EDGAR: Feb 3, 2026, 06:38 ET
- Period: 2026-02-03
- Accession: 0001104659-26-009495
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/310158/000110465926009495/tm264564d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/310158/000110465926009495/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/310158/000110465926009495/tm264564d1_8k.htm

Filed Feb 3, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-009495. Last ingested by Listed: Nov 4, 2026, 17:11 ET. No prices; not investment advice.